Company Profile

IFCI LTD.

NSE : IFCIBSE : 500106ISIN CODE : INE039A01010Industry : Finance Term LendingHouse : PSU
BSE6.570.11 (+1.7 % )
PREV CLOSE (Rs.) 6.46
OPEN PRICE (Rs.) 6.50
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 447208
TODAY'S LOW / HIGH (Rs.)6.44 6.60
52 WK LOW / HIGH (Rs.)3.1 9.31
NSE6.55 0.1 (+1.55 % )
PREV CLOSE(Rs.) 6.45
OPEN PRICE (Rs.) 6.50
BID PRICE (QTY) 6.55 (2425 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 2197723
TODAY'S LOW / HIGH(Rs.) 6.45 6.60
52 WK LOW / HIGH (Rs.)3.1 9.35

Company News

Date Heading Details
10-Aug-2020 IFCI informs about credit rating <P align=justify>IFCI has informed that Rating Agency, Care Ratings has re-affirmed the ratings of debt instruments of the company as enclosed.<P align=justify>The above information is a part of company's filings submitted to BSE.<P><BR>
30-Jun-2020 IFCI raises Rs 200 crore through bonds <p align="justify">IFCI has raised Rs 200 crore through Non-Convertible Bonds and allotted 9.40% p.a. 2000 number of Non-Convertible Bonds of face value of Rs 10 lakh each on Private Placement basis. The date of maturity of the above Non-Convertible Bonds will be April 21, 2023. The Committee of Directors at its Meeting held on June 29, 2020 has approved and allotted the same.<p align="justify">IFCI was established with intent to provide long-term finance needs of the industrial sector. It founded and developed various institutions namely ICRA for credit assessment rating, Tourism Finance Corporation of India (TFCI) for promotion of the hospitality industry, among others.</p>
10-Jun-2020 IFCI informs about record date <p align="justify">IFCI has informed that payment of interest is due on July 13, 2020 for 8.19% IFCI SLR Bonds - Series 60-R (ISIN - INE039A09187). Record date is 15 days before the date of payment and the same falls on June 27, 2020. However, June 27, 2020 being a holiday, hence the Record Date will fall on June 26, 2020.<p align="justify">The above information is a part of company's filings submitted to BSE.</p>
22-Apr-2020 IFCI submits confirmation certificate <P align=justify>Pursuant to the provisions of Regulation 74(5) of the SEBI (Depositories &amp; Participants) Regulations, 2018, IFCI has informed about submission of the confirmation certificate issued by the Registrar &amp; Share Transfer Agent for the quarter ended March 31, 2020.<P>The above information is a part of company's filings submitted to BSE.<BR>
20-Apr-2020 IFCI informs about outcome of board meeting <P align=justify>IFCI has informed that the Board at its Meeting held on April 20, 2020 has approved the preferential Issue of Equity Shares aggregating to Rs 200 crore to the Promoter, Govt. of India, subject to the approval of the Shareholders; and approved convening of the Extra-Ordinary General Meeting of the Shareholders of the Company on Wednesday, May 20, 2020, through VC/OAVM to consider and approve the issue of equity shares by way of preferential Allotment to Govt. of India.<P align=justify>The above information is a part of company's filings submitted to BSE.<BR>
05-Feb-2020 Reliance Industries, Apollo Micro Systems and Cadila Healthcare to see some action today <p align="justify"><strong>Reliance Industries</strong> has acquired additional 65,956 equity shares, representing 10.9% of the equity share capital, of Saavn Media (Saavn India) from the existing shareholders for a total consideration of Rs 653.93 crore on February 3, 2020. After acquisition, the company will hold 94.4% of the equity share capital of Saavn India.<p align="justify"><strong>Apollo Micro Systems</strong> has duly signed the Investment cum Shareholders Agreement with Ananya SIP RF Technologies (ASIP RF) in order to acquire majority stake in ASIP RF ie. 51 % equity share capital. The acquisition aims to expand the business towards new technologies by establishing a RF &amp; Microwave Design cum production facility along with integration facility. <p align="justify">The USFDA has inspected the manufacturing facility of Alidac Pharmaceuticals, <strong>Cadila Healthcare's</strong> wholly-owned subsidiary, located at SEZ, Ahmedabad from January 27 to February 4, 2020. At the end of the inspection, no observation (483) is issued. The site manufactures oncology injectables for the regulated markets.<p align="justify"><strong>Sun Pharmaceutical Industries</strong> has launched ABSORICA LD (isotretinoin) capsules in U.S. for the management of severe recalcitrant nodular acne in patients 12 years of age and older. ABSORICA LD is the only isotretinoin formulation to feature Sun Pharma's micronization technology, which utilizes micronized particles to optimize absorption at a 20% lower dose. ABSORICA LD can be taken with or without food. <p align="justify"><strong>Balmer Lawrie &amp; Company</strong> has received approval to exit from start-up- ‘Kanpur Flowercycling' by sale of 479 equity shares held by the Company to IAN Fund and IAN individuals at a total consideration of Rs 95.14 lakh. The Board of Directors of the Company at its meeting held on February 04, 2020 has approved the same.<p align="justify"><strong>Lumax Industries</strong> has redeemed commercial paper of Rs 50 crore on February 3, 2020. The said commercial paper was issued on November 7, 2019. <p align="justify"><strong>IFCI</strong> has completed the stake sale of National Stock Exchange of India (NSE) and further received an amount of approximately Rs 178.65 crore.</p>
04-Feb-2020 IFCI divests stake in NSE <p align="justify">IFCI has completed the stake sale of National Stock Exchange of India (NSE) and further received an amount of approximately Rs 178.65 crore.<p align="justify">Earlier, the company has received bids for sale of 1,20,66,871 equity shares comprising of 2.44% of the total equity shares in NSE. <p align="justify">IFCI was established with intent to provide long-term finance needs of the industrial sector. It founded and developed various institutions namely ICRA for credit assessment rating, Tourism Finance Corporation of India (TFCI) for promotion of the hospitality industry, among others.</p>
31-Jan-2020 IFCI informs about board meeting <p align="justify">IFCI has informed that pursuant to the provision of Regulations 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, a meeting of the Board of Directors of the Company is scheduled to be held on Thursday, February 13, 2020, to consider and approve the Standalone and Consolidated Financial Results of the Company for the quarter ended December 31, 2019. In view of the above, and in continuation to Letter No: IFCl/CS/2019-1050 dated December 30, 2019; the trading window shall remain closed till Saturday, February 15, 2020, for the aforesaid purpose.<p align="justify">The above information is a part of company's filings submitted to BSE.</p>
28-Jan-2020 IFCI informs about payment of interest <P align=justify>IFCI has confirmed that payment of interest was due on January 25, 2020 for 9.75% Fully Unsecured Non-Convertible Regular Return Bonds in the form of Promissory Notes - Series - 47 (ISIN - INE039A09LC6). However, as January 25-26, 2020 being holidays, hence as per the Information Memorandum, the payment was made on January 27, 2020.&nbsp;<P align=justify>The above information is a part of company's filings submitted to BSE.
09-Jan-2020 IFCI informs about issue of duplicate share certificate <p align="justify">Pursuant to the provisions of Regulation 39 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, IFCI has informed that it has enclosed herewith the request received for issue of duplicate share certificates. <br></p><p align="justify">The above information is a part of company's filings submitted to BSE.</p>